Ambient AI Clinical Trial (NCT07598721) | Clinical Trial Compass
CompletedNot Applicable
Ambient AI Clinical Trial
United States139 participantsStarted 2024-12-19
Plain-language summary
This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be recruited from three medical specialties, including primary care, oncology, and urology. The study will enroll providers and randomize them to an intervention group (access to the ambient AI scribe product) or a control group (routine patient care). Providers will be evaluated for burnout and task load measures through digital surveys at the beginning, middle, and end of the study. Provider electronic health record (EHR) usage data will also be evaluated for time spent documenting, time spent after hours on days with scheduled clinical care, and time between the start of the clinical encounter and signing it.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Provider is an employee of the University of Washington Medicine.
* Clinical specialty of primary care, oncology, or urology.
* Clinical full-time equivalent (FTE) of 0.2 or greater (provider must have an outpatient clinic of at least 20% of an FTE).
* Provider is a physician or an advanced practice provider.
Exclusion Criteria:
* Trainees (e.g., medical students, residents, or fellows)
* Provider does not have access to a mobile device that is compatible with the ambient AI scribe service (e.g., Android mobile phone).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied how an AI scribe tool affected physician burnout and workload — has our clinic or practice already started using this kind of ambient AI technology, and if so, how might that change the way my appointments are documented?
2Since this trial is now completed and measured things like physician fulfillment and cognitive load rather than patient health outcomes, what do the results actually tell us about whether this technology is safe and beneficial for patients like me?
3The trial tracked how often doctors actually used the AI scribe — does that mean adoption was inconsistent, and is there any chance my own doctor might be using it in a way that's still being evaluated?
4Because this study focused on the doctor's experience rather than patient outcomes, are there any separate studies I should ask about that looked specifically at whether AI-assisted note-taking affects the accuracy of my medical records or the quality of my care?
5Given that this trial is already completed, has our health system reviewed the results, and would it be worth discussing whether those findings change anything about how my visits are being recorded going forward?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Professional Fulfillment Index (PFI)
Timeframe: Surveyed at enrollment (day 0 of pilot), midpoint (day 75), and end of pilot (day 150)
2
Mean Score on NASA Task Load Index (NASA-TLX)
Timeframe: Surveyed at enrollment (day 0 of pilot), midpoint (day 75), and end of pilot (day 150)
3
Ambient AI scribe utilization rate (%)
Timeframe: Through study completion, up to 150 days after the start of the pilot.